Integrative Transcriptome Analyses of the Human Fallopian Tube: Fimbria and Ampulla-Site of Origin of Serous Carcinoma of the Ovary.

ampulla differentially expressed genes (DEGs), laser capture microdissection fallopian tube fimbria ovarian cancer transcriptomic analysis

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
27 Apr 2020
Historique:
received: 31 03 2020
revised: 20 04 2020
accepted: 24 04 2020
entrez: 1 5 2020
pubmed: 1 5 2020
medline: 1 5 2020
Statut: epublish

Résumé

Epithelial ovarian cancer represents a group of heterogeneous diseases with high grade serous cancer (HGSC) representing the most common histotype. Molecular profiles of precancerous lesions found in the fallopian tube have implicated this tissue as the presumptive site of origin of HGSC. Precancerous lesions are primarily found in the distal fallopian tube (fimbria), near the ovary relative to the proximal tissue (ampulla), nearer to the uterus. The proximity of the fimbria to the ovary and the link between ovulation, through follicular fluid release, and ovarian cancer risk led us to examine transcriptional responses of fallopian tube epithelia (FTE) at the different anatomical sites of the human fallopian tube. Gene expression profiles of matched FTE from the fimbria and from premenopausal women resulted in differentially expressed genes (DEGs): CYYR1, SALL1, FOXP2, TAAR1, AKR1C2/C3/C4, NMBR, ME1 and GSTA2. These genes are part of the antioxidant, stem and inflammation pathways. Comparisons between the luteal phase (post-ovulation) to the follicular phase (pre-ovulation) demonstrated greater differences in DEGs than a comparison between fimbria and fallopian tube anatomical differences alone. This data suggests that cyclical transcriptional changes experienced in pre-menopause are inherent physiological triggers that expose the FTE in the fimbria to cytotoxic stressors. These cyclical exposures induce transcriptional changes reflective of genotoxic and cytotoxic damage to the FTE in the fimbria which are closely related to transcriptional and genomic alterations observed in ovarian cancer.

Identifiants

pubmed: 32349388
pii: cancers12051090
doi: 10.3390/cancers12051090
pmc: PMC7281286
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : NCI NIH HHS
ID : P30 CA240139
Pays : United States
Organisme : Congressionally Directed Medical Research Programs
ID : w81wh-0701-0371
Organisme : Congressionally Directed Medical Research Programs
ID : W81XWH-18-1-0072
Organisme : NCI NIH HHS
ID : P30CA240139
Pays : United States

Références

Reprod Biol Endocrinol. 2014 Jul 06;12:60
pubmed: 24997727
Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):132-9
pubmed: 19124490
Mol Cell Probes. 2005 Aug;19(4):261-6
pubmed: 15979276
Bioinformatics. 2010 Oct 1;26(19):2363-7
pubmed: 20688976
Nat Commun. 2016 May 24;7:11620
pubmed: 27216078
Proc Natl Acad Sci U S A. 2011 Jan 25;108(4):1462-7
pubmed: 21220312
Cell Rep. 2016 Jul 19;16(3):878-95
pubmed: 27396332
J Pathol. 2007 Jan;211(1):26-35
pubmed: 17117391
Cancers (Basel). 2018 Nov 12;10(11):
pubmed: 30424539
Curr Top Cell Regul. 1996;34:159-87
pubmed: 8646847
Bioinformatics. 2012 Mar 15;28(6):882-3
pubmed: 22257669
Neoplasia. 2011 Oct;13(10):899-911
pubmed: 22028616
Stem Cells. 2012 Nov;30(11):2487-97
pubmed: 22911892
Am J Surg Pathol. 2009 Mar;33(3):376-83
pubmed: 19011565
Front Oncol. 2014 May 13;4:104
pubmed: 24860785
Nat Commun. 2015 Dec 08;6:8989
pubmed: 26643275
Gynecol Oncol. 2006 Jan;100(1):58-64
pubmed: 16137750
Carcinogenesis. 2015 Nov;36(11):1419-28
pubmed: 26363031
Am J Surg Pathol. 2007 Feb;31(2):161-9
pubmed: 17255760
Gynecol Oncol. 2014 Feb;132(2):322-7
pubmed: 24355484
Nat Commun. 2017 Oct 17;8(1):990
pubmed: 29042553
Nat Rev Cancer. 2015 Nov;15(11):668-79
pubmed: 26493647
Oncol Rep. 2012 Jun;27(6):1873-8
pubmed: 22469973
Mod Pathol. 2009 Mar;22(3):345-50
pubmed: 19151662
Oxid Med Cell Longev. 2010 Sep-Oct;3(5):317-24
pubmed: 21150337
Proc Natl Acad Sci U S A. 2011 May 3;108(18):7547-52
pubmed: 21502498
J Clin Oncol. 2008 Nov 10;26(32):5284-93
pubmed: 18854563
Gynecol Oncol. 2015 Sep;138(3):741-9
pubmed: 26080287
Nat Protoc. 2012 Sep;7(9):1755-64
pubmed: 22936217
Clin Cancer Res. 2008 Jul 1;14(13):4067-78
pubmed: 18593983
J Cell Sci. 2013 Apr 1;126(Pt 7):1626-36
pubmed: 23418348
Front Oncol. 2016 May 02;6:108
pubmed: 27200296
Front Oncol. 2014 Jan 23;4:5
pubmed: 24478985
J Pathol. 2019 May;248(1):41-50
pubmed: 30560554
Clin Cancer Res. 2012 Nov 15;18(22):6199-207
pubmed: 22967960
Am J Pathol. 2016 Apr;186(4):733-47
pubmed: 27012190
Cancers (Basel). 2018 Nov 28;10(12):
pubmed: 30486509
Clin Cancer Res. 2012 Aug 15;18(16):4334-44
pubmed: 22753593
Mod Pathol. 2014 Jul;27(7):991-1001
pubmed: 24336157
Reprod Biomed Online. 2013 Oct;27(4):423-35
pubmed: 23953067
Proc Natl Acad Sci U S A. 1996 Mar 19;93(6):2442-7
pubmed: 8637893
Int J Mol Sci. 2018 Aug 24;19(9):
pubmed: 30149579
Cancer Cell. 2013 Dec 9;24(6):751-65
pubmed: 24332043
J Pathol. 2017 Sep;243(1):26-36
pubmed: 28678427
J Pathol. 2011 Sep;225(1):106-17
pubmed: 21744340
Gynecol Oncol. 2008 May;109(2):168-73
pubmed: 18342932
Histopathology. 2013 Jan;62(1):44-58
pubmed: 23240669
Cells. 2015 Jul 31;4(3):315-30
pubmed: 26264028
Nat Commun. 2017 Oct 23;8(1):1093
pubmed: 29061967
Biochim Biophys Acta. 2014 Sep;1843(9):1875-85
pubmed: 24851839
Biostatistics. 2010 Apr;11(2):242-53
pubmed: 20097884
Facts Views Vis Obgyn. 2013;5(4):292-7
pubmed: 24753957

Auteurs

Ramlogan Sowamber (R)

Division of Gynecologic Oncology, Sylvester Comprehensive Cancer Center, Leonard Miller School of Medicine, University of Miami, 1550 NW 10th Ave, Miami, 33134 FL, USA.

Omar Nelson (O)

Division of Gynecologic Oncology, Sylvester Comprehensive Cancer Center, Leonard Miller School of Medicine, University of Miami, 1550 NW 10th Ave, Miami, 33134 FL, USA.

Leah Dodds (L)

Division of Gynecologic Oncology, Sylvester Comprehensive Cancer Center, Leonard Miller School of Medicine, University of Miami, 1550 NW 10th Ave, Miami, 33134 FL, USA.

Victoria DeCastro (V)

Division of Gynecologic Oncology, Sylvester Comprehensive Cancer Center, Leonard Miller School of Medicine, University of Miami, 1550 NW 10th Ave, Miami, 33134 FL, USA.

Iru Paudel (I)

Division of Gynecologic Oncology, Sylvester Comprehensive Cancer Center, Leonard Miller School of Medicine, University of Miami, 1550 NW 10th Ave, Miami, 33134 FL, USA.

Anca Milea (A)

Ontario Cancer Institute, Princess Margaret Cancer Center, University Health Network, Toronto, ON M5G 0A2, Canada.

Michael Considine (M)

Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21231, USA.

Leslie Cope (L)

Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21231, USA.

Andre Pinto (A)

Department of Pathology, University of Miami Miller School of Medicine, Miami, FL 33136, USA.

Matthew Schlumbrecht (M)

Division of Gynecologic Oncology, Sylvester Comprehensive Cancer Center, Leonard Miller School of Medicine, University of Miami, 1550 NW 10th Ave, Miami, 33134 FL, USA.

Brian Slomovitz (B)

Division of Gynecologic Oncology, Sylvester Comprehensive Cancer Center, Leonard Miller School of Medicine, University of Miami, 1550 NW 10th Ave, Miami, 33134 FL, USA.

Patricia A Shaw (PA)

Ontario Cancer Institute, Princess Margaret Cancer Center, University Health Network, Toronto, ON M5G 0A2, Canada.

Sophia H L George (SHL)

Division of Gynecologic Oncology, Sylvester Comprehensive Cancer Center, Leonard Miller School of Medicine, University of Miami, 1550 NW 10th Ave, Miami, 33134 FL, USA.

Classifications MeSH